Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
T. Vandemoortele, S. Laroumagne, O. Bylicki, H. Dutau, P. Astoul (Marseille, France). F-18 FDG PET scan 20 years after talc pleurodesis: Report of 3 cases. Eur Respir J 2012; 40: Suppl. 56, 4621

Member's Comments

No comment yet.

Related content which might interest you: Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET) Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 A comparison of fluorodeoxyglucose positron emission tomography (FDG-PET) and transthoracic needle biopsy (TNB) in the management of single pulmonary nodules (SPN) Source: Annual Congress 2004 - Pneumothorax, chest drains Year: 2004 Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Imaging can replace mediastinoscopy: CON Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Accuracy of positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) in diagnosis of recurrence of lung cancer after curative first-line therapy: visual and semiquantitative PET analysis Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer Year: 2008 Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 (18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Clinicopathologic comparison of computed tomography and positron emission tomography scanning for mediastinal staging in NSCLC Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010 Increased FDG uptake on 18F-FDG PET/CT in residual lesions of tuberculosis Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 EBUS-TBNA in positron emission tomography (PET) positive mediastinal lymph nodes in previously radically treated malignancies Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Imaging the pleura: HRCT and PET scan Source: Hands-on Course 2012 - Thoracoscopy and Pleural Techniques Year: 2012 Rebuttal Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Imaging the pleura: CT scan, MRI and PET Source: ERS Skills Course 2016 Year: 2016 Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013 Positron emission tomography in the diagnostic work-up of screening-detected lung nodules Source: Eur Respir J 2015; 45: 501-510 Year: 2015